Application of PD-L1 Antibody Clone SP263 on Paired Fine Needle Aspiration Smears, Cell Blocks and Surgical Specimens of Non-Small Cell Lung Cancer

被引：0
|
作者：
Wang, Hongbo [1 ]
Liu, Lina [2 ]
Rabie, Lubna [3 ]
Zreik, Riyam T. [4 ]
Rao, Arundhati [5 ]
Leng, Bing
机构：
[1] Baylor Scott & White Hlth, Temple, TX USA
[2] Baylor Scott & White Hlth, Belton, TX USA
[3] Baylor Scott & White, Temple, TX USA
[4] Baylor Scott & White Med Ctr, Temple, TX USA
[5] Scott & White Mem Hosp & Clin, Temple, TX USA
来源：
MODERN PATHOLOGY | 2018年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
505
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [1] Application of PD-L1 Antibody Clone SP263 on Paired Fine Needle Aspiration Smears, Cell Blocks and Surgical Specimens of Non-Small Cell Lung Cancer
    Wang, Hongbo
    Liu, Lina
    Rabie, Lubna
    Zreik, Riyam T.
    Rao, Arundhati
    Leng, Bing
    LABORATORY INVESTIGATION, 2018, 98 : 182 - 182
  • [2] Clinical significance of ≥ 50% PD-L1 expression with the SP263 monoclonal antibody in non-small cell lung cancer patients
    Li, Wenbin
    Song, Peng
    Guo, Lei
    Liu, Xiuyun
    Guo, Changyuan
    Ying, Jianming
    Gao, Shugeng
    THORACIC CANCER, 2019, 10 (02) : 175 - 182
  • [3] Comparison of PD-L1 Assays in Non-small Cell Lung Cancer: 22C3 pharmDx and SP263
    Fujimoto, Daichi
    Yamashita, Daisuke
    Fukuoka, Junya
    Kitamura, Yuka
    Hosoya, Kazutaka
    Kawachi, Hayato
    Sato, Yuki
    Nagata, Kazuma
    Nakagawa, Atsushi
    Tachikawa, Ryo
    Date, Naoki
    Sakanoue, Ichiro
    Hamakawa, Hiroshi
    Takahashi, Yutaka
    Tomii, Keisuke
    ANTICANCER RESEARCH, 2018, 38 (12) : 6891 - 6895
  • [4] Performance of Ventana SP263 PD-L1 assay in endobronchial ultrasound guided-fine-needle aspiration derived non-small-cell lung carcinoma samples
    Chauhan, Aastha
    Siegel, Lianne
    Freese, Rebecca
    Racila, Emilian
    Stewart, Jimmie, III
    Amin, Khalid
    DIAGNOSTIC CYTOPATHOLOGY, 2021, 49 (03) : 355 - 362
  • [5] Digital SP263 PD-L1 tumor cell scoring in non-small cell lung cancer achieves comparable outcome prediction to manual pathology scoring
    Prizant, Hen
    Shamshoian, John
    Abel, John
    Beck, Andrew
    Chambre, Laura
    Hennek, Stephanie
    Koeppen, Hartmut
    Ruderman, Daniel
    Das Thakur, Meghna
    Montalto, Michael
    Trotter, Benjamin
    Wapinski, Ilan
    Zou, Wei
    Srivastava, Minu K.
    Giltnane, Jennifer
    CANCER RESEARCH, 2023, 83 (07)
  • [6] PD-L1 Immunohistochemistry for Non-Small Cell Lung Cancer on Cytology Specimens
    Banach, Bridget
    Antic, Tatjana
    Mueller, Jeffrey
    LABORATORY INVESTIGATION, 2018, 98 : 133 - 133
  • [7] PD-L1 Immunohistochemistry for Non-Small Cell Lung Cancer on Cytology Specimens
    Banach, Bridget
    Antic, Tatjana
    Mueller, Jeffrey
    MODERN PATHOLOGY, 2018, 31 : 133 - 133
  • [8] Comprehensive Assessment of PD-L1 Immunohistochemistry on Paired Tissue and Cytology Specimens in Non-Small Cell Lung Cancer
    Gagne, A.
    Orain, M.
    Ionescu, D.
    Tsao, M.
    Joubert, D.
    Joubert, P.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S760 - S760
  • [9] Expression of PD-L1 Is Associated with Inflammatory Microenvironment in Surgical Specimens of Non-Small Cell Lung Cancer
    Simundza, Ivan
    Krnic, Dragan
    Juricic, Josko
    Benzon, Benjamin
    Simundza, Rina
    Stanicic, Ivan Mario
    Capkun, Vesna
    Vukojevic, Katarina
    Durdov, Merica Glavina
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):
  • [10] Inter-rater reliability of programmed death ligand 1 ( PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in non-small cell lung cancer (NSCLC)
    Williams, G. H.
    Nicholson, A. G.
    Snead, D. R. J.
    Thunnissen, E.
    Lantuejoul, S.
    Cane, P.
    Kerr, K. M.
    Loddo, M.
    Scott, M.
    Scorer, P. W.
    Barker, C.
    ANNALS OF ONCOLOGY, 2018, 29
12345